Newly developed retatrutide, a dual -action treatment targeting simultaneously GLP-1 and GIP receptors, is sparking considerable interest within the weight loss community. Initial clinical trials have revealed substantial losses in physical size and improvements in health markers for people with overweight. Experts believe this unique approach … Read More